HitGen, Inc. Hits Day High with 7.28% Surge in Strong Intraday Performance

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 7.28% on August 10, 2026. The stock reached an intraday high of CNY 38.94, reflecting strong market activity. Over the past year, HitGen has demonstrated impressive growth, with a remarkable 61.55% increase, significantly outperforming the China Shanghai Composite, which rose only 9.12% during the same period. The company's financial metrics indicate robust health, highlighted by a net profit growth of 114.98% and a pre-tax profit of CNY 43.75 million, which has surged by 150.73%. Additionally, HitGen's operating cash flow reached a record high of CNY 204.8 million, and its return on capital employed (ROCE) stands at 8.01%. With a market capitalization of CNY 14,577 million and a price-to-earnings ratio of 87.00, HitGen continues to showcase its position as a reliable performer in the market. The stock's performance over various time frames, including a 138.71% increase over three years, underscores its strong market presence and operational efficiency.